ARROWHEAD PHARMACEUTICALS, INC. - ARWR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | — | A | A | 11,882.0 | 0.0 | 0.0 | 11,882.0 | View | |
| May 14, 2026 | — | S | D | 2,970.0 | 76.88 | 228,333.6 | 52,012.0 | View | |
| Apr 24, 2026 | Chief Medical Officer | S | D | 10,000.0 | 75.0 | 750,000.0 | 226,958.0 | View | |
| Apr 24, 2026 | Chief Financial Officer | S | D | 8,730.0 | 71.92 | 627,861.6 | 162,905.0 | View | |
| Apr 24, 2026 | Chief Financial Officer | S | D | 1,157.0 | 70.45 | 81,510.65 | 171,635.0 | View | |
| Apr 24, 2026 | Chief Financial Officer | S | D | 3,208.0 | 70.11 | 224,912.88 | 172,792.0 | View | |
| Mar 09, 2026 | Chief Medical Officer | S | D | 10,000.0 | 64.19 | 641,900.0 | 236,958.0 | View |